CX3CR1

CX3C motif chemokine receptor 1 (Fractalkine receptor)

Also known as: CX3CR1, CMKBRL1, GPR13

Biology & Mechanism

CX3CR1 (the Fractalkine receptor) is the primary "tethering" axis between microglia and neurons. It binds exclusively to CX3CL1 (Fractalkine), which is constitutively expressed on the surface of healthy neurons. This one-to-one interaction exerts a critical, continuous inhibitory signal that prevents microglia from erroneously attacking viable neuronal bodies and synapses.

When neurons undergo stress or undergo apoptosis, they downregulate CX3CL1, releasing the microglial "brake." This signals the microglia that the neuron is damaged and vulnerable, initiating phagocytic cleanup. Without CX3CR1 signaling, microglia become hyper-vigilant and pathologically over-prune synapses, leading to severe connectivity deficits and cognitive behavioral abnormalities in animal models.

In neurodegenerative contexts like Alzheimer's and ALS, the disruption of the CX3CL1-CX3CR1 axis precipitates rampant microglial toxicity. Strategies seeking to leverage this pathway are heavily focused on mimicking the natural neuro-immune suppression signal to force hyper-reactive microglia back into a subdued, non-destructive surveillance state in the face of ongoing neuroinflammation.

Open Questions

  • Does CX3CR1 loss of expression in disease-associated microglia represent a protective or harmful adaptation?
  • Can CX3CR1-CX3CL1 signaling be harnessed therapeutically to maintain microglial homeostasis?
  • How does CX3CR1 expression correlate with microglial surveillance velocity in vivo?

Sources

Evidence Status

human tissuesingle-cell RNA-seqanimal modelin vitro assay

Disease Links

  • Alzheimer's disease
  • Parkinson's disease
  • Multiple sclerosis
  • Amyotrophic lateral sclerosis

Last reviewed: June 1, 2026